Mismatch Negativity Indices as a Prognostic Factor for Remission in Schizophrenia
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objective: Mismatch negativity (MMN) is known to be associated with neuro-cognition and functional outcomes. Remission and recovery rates are related to the neuro-cognition of patients with schizophrenia. The present study explored the relationship of MMN with remission in patients with schizophrenia. Methods: Forty patients with schizophrenia were recruited and divided into two groups, with or without remission, according to the Remission in Schizophrenia Working Group criteria (RSWGcr). Symptom severity (Positive and Negative Syndrome Scale, PANSS), cognitive function, functional outcome, and MMN of the patients were evaluated. A regression analysis was used to identify the factors that significantly predicted symptom improvement and remission including MMN at frontal site assessed at baseline, and anticipated clinical variables as predictive factors. Results: MMN amplitudes in frontal sites were further decreased in the groups without remission compared to the groups with remission. MMN amplitude was significantly correlated with measures of symptom change and functional outcome measurements in patients with schizophrenia. Regression analysis revealed that symptom severity and MMN significantly predicted remission in patients with schizophrenia. Symptom improvement significantly predicted PANSS at baseline, illness duration, and antipsychotic dose, as did MMN amplitude at frontal site. Conclusion: Our results suggest that MMN reflected symptom improvement and remission in patients with schizophrenia. MMN indices appear to be promising candidates as predictive factors for schizophrenia remission.
Abstract
Objective: Mismatch negativity (MMN) is known to be associated with neuro-cognition and functional outcomes. Remission and recovery rates are related to the neuro-cognition of patients with schizophrenia. The present study explored the relationship of MMN with remission in patients with schizophrenia. Methods: Forty patients with schizophrenia were recruited and divided into two groups, with or without remission, according to the Remission in Schizophrenia Working Group criteria (RSWGcr). Symptom severity (Positive and Negative Syndrome Scale, PANSS), cognitive function, functional outcome, and MMN of the patients were evaluated. A regression analysis was used to identify the factors that significantly predicted symptom improvement and remission including MMN at frontal site assessed at baseline, and anticipated clinical variables as predictive factors. Results: MMN amplitudes in frontal sites were further decreased in the groups without remission compared to the groups with remission. MMN amplitude was significantly correlated with measures of symptom change and functional outcome measurements in patients with schizophrenia. Regression analysis revealed that symptom severity and MMN significantly predicted remission in patients with schizophrenia. Symptom improvement significantly predicted PANSS at baseline, illness duration, and antipsychotic dose, as did MMN amplitude at frontal site. Conclusion: Our results suggest that MMN reflected symptom improvement and remission in patients with schizophrenia. MMN indices appear to be promising candidates as predictive factors for schizophrenia remission.
참고문헌 (42)
- Jeong Ha Park, "Effects of Amisulpride Adjunctive Therapy on Working Memory and Brain Metabolism in the Frontal Cortex of Patients with Schizophrenia: A Preliminary Positron Emission Tomography", Computerized Tomography Investigation, 2019, pp.17(2), 250~260[DOI]
- Harvey PD, "Toward a terminology for functional recovery in schizophrenia: is functional remission a viable concept?", Schizophr Bull, 35, pp.300~306 (2009)
- Nasrallah HA, "Improving patient outcomes in schizophrenia : achieving remission", J Psychopharmacol, 20(6 Suppl), pp.57~61 (2006)
- Bodén R, "Association between symptomatic remission and functional outcome in first-episode schizophrenia", Schizophr Res, 107, pp.232~237 (2009)
- Brissos S, "Symptomatic remission in schizophrenia patients : relationship with social functioning, quality of life, and neurocognitive performance", Schizophr Res, 129, pp.133~136 (2011)
- Valencia M, "Predicting functional remission in patients with schizophrenia : a cross-sectional study of symptomatic remission, psychosocial remission, functioning, and clinical outcome", Neuropsychiatr Dis Treat, 11, pp.2339~2348 (2015)
- Torgalsbøen AK, "Neurocognitive predictors of remission of symptoms and social and role functioning in the early course of first-episode schizophrenia", Psychiatry Res, 216, pp.1~5 (2014)
- Kawakubo Y, "Support for an association between mismatch negativity and social functioning in schizophrenia", Prog Neuropsychopharmacol Biol Psychiatry, 30, pp.1367~1368 (2006)
- Rasser PE, "Gray matter deficits, mismatch negativity, and outcomes in schizophrenia", Schizophr Bull, 37, pp.131~140 (2011)
- Näätänen R, "The mismatch negativity(MMN)--a unique window to disturbed central auditory processing in ageing and different clinical conditions", Clin Neurophysiol, 123, pp.424~458 (2012)
- Näätänen R, "Early selective-attention effect on evoked potential reinterpreted", Acta Psychol(Amst), 42, pp.313~329 (1978)
- Javitt DC, "Has an angel shown the way? Etiological and therapeutic implications of the PCP", NMDA model of schizophrenia, 2012, pp.38, 958~966
- Light GA, "Mismatch negativity deficits are associated with poor functioning in schizophrenia patients", Arch Gen Psychiatry, 62, pp.127~136 (2005)
- Salisbury DF, "Mismatch negativity in chronic schizophrenia and first-episode schizophrenia", Arch Gen Psychiatry, 59, pp.686~694 (2002)
- Umbricht DS, "Electrophysiological indices of automatic and controlled auditory information processing in first-episode, recent-onset and chronic schizophrenia", Biol Psychiatry, 59, pp.762~772 (2006)
- Kim M, "Impaired mismatch negativity is associated with current functional status rather than genetic vulnerability to schizophrenia", Psychiatry Res, 222, pp.100~106 (2014)
- Umbricht D, "Mismatch negativity in schizophrenia : a meta-analysis", Schizophr Res, 76, pp.1~23 (2005)
- Kim M, "Predicting remission in subjects at clinical high risk for psychosis using mismatch negativity", Schizophr Bull, 44, pp.575~583 (2018)
- Andreasen NC, "Remission in schizophrenia : proposed criteria and rationale for consensus", Am J Psychiatry, 162, pp.441~449 (2005)
- Lambert M, "Remission in schizophrenia : validity, frequency, predictors, and patients’ perspective 5 years later", Dialogues Clin Neurosci, 12, pp.393~407 (2010)
- van Os J, "Standardized remission criteria in schizophrenia", Acta Psychiatr Scand, 113, pp.91~95 (2006)
- Fukumoto M, "Relation between remission status and attention in patients with schizophrenia", Psychiatry Clin Neurosci, 68, pp.234~241 (2014)
- First MB, "User’s guide for the structured clinical interview for DSM-IV axis II personality disorders: SCID-II" (1997), American Psychiatric Press
- Burkey JM, "Clinical utility of the 512-Hz Rinne tuning fork test", Am J Otol, 19, pp.59~62 (1998)
- Leucht S, "Dose equivalents for second-generation antipsychotics : the minimum effective dose method", Schizophr Bull, 40, pp.314~326 (2014)
- Pinna F, "Criteria for symptom remission revisited : a study of patients affected by schizophrenia and schizoaffective disorders", BMC Psychiatry, 13, pp.235~ (2013)
- Semlitsch HV, "A solution for reliable and valid reduction of ocular artifacts, applied to the P300 ERP", Psychophysiology, 23, pp.695~703 (1986)
- Thomas ML, "Modeling deficits from early auditory information processing to psychosocial functioning in schizophrenia", JAMA Psychiatry, 74, pp.37~46 (2017)
- Wynn JK, "Mismatch negativity, social cognition, and functioning in schizophrenia patients", Biol Psychiatry, 67, pp.940~947 (2010)
- Lee SH, "Mismatch negativity is a stronger indicator of functional outcomes than neurocognition or theory of mind in patients with schizophrenia", Prog Neuropsychopharmacol Biol Psychiatry, 48, pp.213~219 (2014)
- Catts SV, "Brain potential evidence for an auditory sensory memory deficit in schizophrenia", Am J Psychiatry, 152, pp.213~219 (1995)
- Immonen J, "Age at onset and the outcomes of schizophrenia : a systematic review and meta-analysis", Early Interv Psychiatry, 11, pp.453~460 (2017)
- Stratta P, "Short-term remission in schizophrenia as a combination of several outcome measures", Psychiatry Res, 209, pp.401~405 (2013)
- Javitt DC, "Impaired mismatch negativity generation reflects widespread dysfunction of working memory in schizophrenia", Arch Gen Psychiatry, 52, pp.550~558 (1995)
- Harms MP, "Structurefunction relationship of working memory activity with hippocampal and prefrontal cortex volumes", Brain Struct Funct, 218, pp.173~186 (2013)
- Green MF, "Cognition in schizophrenia : past, present, and future", Schizophr Res Cogn, 1, pp.e1~e9 (2014)
- Mohn C, "The relationship between IQ and performance on the MATRICS consensus cognitive battery", Schizophr Res Cogn, 1, pp.96~100 (2014)
- Haro JM, "Symptomatic remission and patient quality of life in an observational study of schizophrenia: is there a relationship?", Psychiatry Res, 220, pp.163~169 (2014)
- Fett AK, "The relationship between neurocognition and social cognition with functional outcomes in schizophrenia : a meta-analysis", Neurosci Biobehav Rev, 35, pp.573~588 (2011)
- Bliksted V, "Social cognition and neurocognitive deficits in first-episode schizophrenia", Schizophr Res, 153, pp.9~17 (2014)
- Umbricht D, "Effects of risperidone on auditory event-related potentials in schizophrenia", Int J Neuropsychopharmacol, 2, pp.299~304 (1999)
- Kim JS, "Diagnostic stability of first-episode psychosis and predictors of diagnostic shift from non-affective psychosis to bipolar disorder : a retrospective evaluation after recurrence", Psychiatry Res, 188, pp.29~33 (2011)
